May 13, 2020 / 11:59 AM / 15 days ago

BRIEF-Fulcrum Therapeutics Posts Q1 Loss Per Share Of $0.81

May 13 (Reuters) - Fulcrum Therapeutics Inc:

* FULCRUM THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2020 FINANCIAL RESULTS

* FULCRUM THERAPEUTICS - AS OF MARCH 31, 2020, CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES WERE $81.2 MILLION, AS COMPARED TO $96.7 MILLION AS OF DEC 31, 2019

* FULCRUM THERAPEUTICS INC QTRLY LOSS PER SHARE $0.81

* FULCRUM THERAPEUTICS INC - EXPECTS EXISTING CASH WILL BE SUFFICIENT TO ENABLE IT TO FUND ITS OPERATING EXPENSES INTO Q3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below